摘要
背景:光动力治疗(PDT)在抗癌研究中是一个日益突出的领域。 PDT试剂通常在没有光的情况下是无毒的,并且可以用非电离辐射刺激以“激活”它们的细胞毒性作用。虽然通过允许选择性治疗的局部照射来控制药物的毒性是有利的,但是光敏染料不被分类为化疗药物。过渡金属是具有各种独特性能的极其多用途的化合物,如氧化态,配位数,氧化还原电位和可根据具体用途量身定制的分子几何结构。这使得它们成为优秀的PDT候选物,因为它们的性质可以被操纵以吸收特定范围的光波长,穿过细胞膜或体外靶向特定位点。本文综述了过渡金属PDT试剂的最新进展,重点介绍了一系列金属配合物合成的结构支架,以及它们在存在或不存在照射时的体外细胞毒性。 结论:临床光敏剂如PhotofrinR的成功激发了数千种潜在PDT药物的开发。特别是过渡金属配合物在涉及PDT治疗浸润性癌症时表现出优异的多功能性和多样性。该综述强调了过渡金属PDT试剂在体外和体内高光毒活性方面的许多最新进展。光敏过渡金属配合物由于其固有的物理化学变化已经证明了它们的潜力,使它们能够填补PDT世界的空白
关键词: 光动力疗法,过渡金属,癌症,辐照,光照,活性氧物种。
Current Medicinal Chemistry
Title:Exposing “Bright” Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes
Volume: 25 Issue: 4
关键词: 光动力疗法,过渡金属,癌症,辐照,光照,活性氧物种。
摘要: Background: Photodynamic therapy (PDT) is an increasingly prominent field in anticancer research. PDT agents are typically nontoxic in the absence of light and can be stimulated with nonionising irradiation to “activate” their cytotoxic effect. Photosensitzers are not classified as chemotherapy drugs although it is advantageous to control the toxicity of a drug through localised irradiation allowing for selective treatment. Transition metals are an extremely versatile class of compounds with various unique properties such as oxidation state, coordination number, redox potential and molecular geometry that can be tailored for specific uses. This makes them excellent PDT candidates as their properties can be manipulated to absorb a specific range of light wavelengths, cross cellular membranes or target specific sites in vitro. This article reviews recent advances in transition metal PDT agents, with a focus on structural scaffolds from which several metal complexes in a series are synthesised, as well as their in vitro cytotoxicity in the presence or absence of irradiation.
Conclusion: The success of clinical photoactive agents such as Photofrin® has inspired the development of thousands of potential PDT agents. Transition metal complexes in particular have demonstrated excellent versatility and diversity when it comes to PDT for treatment of invasive cancers. This review has highlighted some of the many recent advances of transition metal PDT agents with high in vitro and in vivo phototoxic activity. Photoactive transition metal complexes have proven their potential due to their inherent physicochemical variety, allowing them to fill a niche in the PDT world.
Export Options
About this article
Cite this article as:
Exposing “Bright” Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes, Current Medicinal Chemistry 2018; 25 (4) . https://dx.doi.org/10.2174/0929867324666170530085123
DOI https://dx.doi.org/10.2174/0929867324666170530085123 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra
Current Genomics The HOX Gene Network as a Potential Target for Cancer Therapy
Current Cancer Therapy Reviews Gabapentin and Pregabalin for the Acute Post-operative Pain Management. A Systematic-narrative Review of the Recent Clinical Evidences
Current Drug Targets Folate Deficiency and Aberrant Expression of DNA Methyltransferase 1 were Associated with Cervical Cancerization
Current Pharmaceutical Design Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Drosophila Neoplasias: Clues Towards the Understanding of Human Cancers
Current Genomics Biological Activity of Carotenoids: Its Implications in Cancer Risk and Prevention
Current Pharmaceutical Biotechnology Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets On the Origin of Epidermal Cancers
Current Molecular Medicine Chemical Constituents and Cytotoxicity of Euphorbia vajravelui
Letters in Organic Chemistry The Antiproliferative Effect of Soy (<i>Glycine max</i>) Isoflavones Contained in a Nutraceutical on Cancer Cell Lines
Current Nutraceuticals The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells
Current Molecular Pharmacology Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A
Anti-Cancer Agents in Medicinal Chemistry Clinical Utility of Combined 18F-Fluoro-2-deoxyglucose Positron Emission Tomography – Computed Tomography in the Evaluation of Gastrointestinal Malignancies
Current Medical Imaging Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy
Current Pharmaceutical Design Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Recent Methods for Assessing Bone Mineral Density, Bone Strength, Fracture Risk and Therapeutic Effects on Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Cellular and Molecular Basis of Health Benefits of Grape Seed Proanthocyanidin Extract
Current Pharmaceutical Biotechnology